Immersive Virtual Reality Training for Phlebotomy Skills in Nursing Students
The Effect of Immersive VR Phlebotomy on Nursing Students Self-efficacy, Anxiety and Clinical Performance: Randomize Clinical Trial
This randomized controlled trial aims to evaluate the effect of immersive virtual reality (VR) training on nursing students' learning outcomes in phlebotomy skills. The study compares immersive VR-based simulation with traditional task trainer-based simulation.
A total sample of undergraduate nursing students is randomly assigned to either the experimental group (VR training) or the control group (task trainer training). The intervention focuses on improving self-efficacy, reducing anxiety, and enhancing clinical performance in venipuncture skills.
Outcomes are measured at three time points: pre-test, immediate post-test, and follow-up. Self-efficacy, anxiety, and clinical performance are assessed using validated scales.
The study seeks to determine whether immersive VR provides a more effective and engaging learning experience compared to conventional simulation methods in nursing education.
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Type d'étude
Inscription (Réel)
Phase
- N'est pas applicable
Contacts et emplacements
Lieux d'étude
-
-
Jerusalem
-
Abū Dīs, Jerusalem, Territoires palestiniens, 5100
- Al-Quds University
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
- Adulte
Accepte les volontaires sains
La description
Inclusion Criteria:
Second-year nursing students who enrolled in the Adult Health Nursing I course, had no prior clinical experience in venipuncture, and were willing to participate in the study. Additional inclusion criteria included the ability to attend training sessions using both immersive virtual reality (VR) and a part-task trainer simulation and commitment to completing all training and assessment sessions. Written informed consent was obtained from all participants before enrollment.
Exclusion Criteria:
if they had previous advanced or extensive practical experience in venipuncture or had participated in external training programs related to the same skill. Additional exclusion criteria included the presence of physical or psychological conditions that could interfere with participation or performance during training, failure to attend scheduled training sessions, incomplete participation in the study procedures, or withdrawal of consent.
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Traitement
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Seul
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Expérimental: Immersive Virtual Reality Training Group
|
Immersive VR-based phlebotomy training simulation designed to improve self-efficacy, reduce anxiety, and enhance clinical performance.
|
|
Comparateur actif: Part-Task Trainer Simulation Group
|
Traditional phlebotomy training using a part-task trainer arm simulation.
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Self-efficacy
Délai: Baseline, immediately post-intervention, and two-week follow-up
|
Measured using a validated self-efficacy scale for clinical skills.
|
Baseline, immediately post-intervention, and two-week follow-up
|
|
Clinical performance
Délai: Baseline, immediately post-intervention, and two-week follow-up
|
Assessed using a structured checklist evaluating steps of the phlebotomy procedure.
|
Baseline, immediately post-intervention, and two-week follow-up
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Anxiety related to phlebotomy skill
Délai: Baseline, immediately post-intervention, and at the 2-week follow-up.
|
State-Trait Anxiety Inventory (STAI-S) - State version (STAI-S)
|
Baseline, immediately post-intervention, and at the 2-week follow-up.
|
Collaborateurs et enquêteurs
Parrainer
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Réel)
Achèvement primaire (Réel)
Achèvement de l'étude (Réel)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Autres numéros d'identification d'étude
- RESC/2026-72
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .